Aller au contenu principal

COVID-19 Epidemiological Bulletin, Afghanistan - Epidemiological Week 17 (24 – 30 Apr 2022)

Pays
Afghanistan
Sources
WHO
Date de publication
Origine
Voir l'original

Highlights of the week

Since the beginning of the pandemic in Feb 2020, a total of 578,482 samples have been tested for COVID-19 through the public laboratories in the country.

In week 17-2022, 3,271 samples were tested in public labs, of which 210 samples tested positive for COVID-19 (percent positivity 6) and 1 new death was reported. This represents 21% and 75% decrease in cases and deaths, compared to week 16 2022, respectively (Table 1).
Cumulatively, 178,901 confirmed cases (overall percent positivity 30.9) of COVID-19 with 7,683 associated deaths (case fatality ratio = 4.29%) have been reported in Afghanistan since Feb 2020.

As of 30th April 2022, 90.4 %, cases have recovered.

In week 17, 2022, the highest numbers of COVID-19 cases were reported in the East and Central East regions (63 and 45 cases, respectively) (Table 2). The top five provinces that reported positive cases included Nangarhar (34 cases), Logar (24 cases), Laghman (15 cases), Takhar (15 cases), and Samangan (15 cases).

The WHO supported building the in-country capacity for genome sequencing, after training of two national staff on sequencing techniques in Dubai (December 2021). The WHO supported the procurement of the Oxford Nanopore Sequencer with the reagents and consumables. Initially, the plan is to conduct genome sequencing for COVID-19, with a plan to expand it to include other high-threat pathogens. The team is currently working on processing the COVID-19 samples for sequencing, the results will be shared when available.

Overall, Afghanistan has reported 4,758 confirmed cases and 97 associated deaths among healthcare workers (HCWs) since 2020.
To date, Herat, Kabul, Nangarhar, Balkh and Kunar reported the highest number of positive cases among HCWs.